Electroretinogram Changes Before and After Intra Vitreal Injection of Ranibizumab for Diabetic Macular Edema

Document Type : Original Articles

Authors

1 Mansoura Ophthalmic Center, Mansoura University

2 Mansoura university Ophthalmic center - EL Gomhoria st. Mansoura university

10.21608/ejomos.2024.320886.1145

Abstract

Objective: To evaluate the role of multifocal Electroretinogram (mf-ERG) in the follow up of DME after intravitreal Anti-VEGFs (Ranibizumab).
Methods: This prospective, case series, interventional, analytic study was held on 25 eyes of 25 patients with DME and had intravitreal injection (IVI) of ranibizumab. Pre-operative investigations included assessment of visual acuity and BVCA and slit lamb biomiocroscopy. Imaging included OCT and electroretinography (ERG) were also conducted. All cases were followed up after one week, one month, two months and three months from each injection by assessment of visual acuity (VA), best corrected visual acuity (BCVA), slit lamb biomiocroscopy (SLB), OCT and ERG.
Results: There was statistically significant change in macular thickness and BCVA after treatment in comparison with pre-treatment. There was statistically significant difference in amplitude p1 in (ring 1, ring 2 and ring 3) between baseline pre and post-treatment. There was statistically significant difference in Implicit time PET P1 in (ring 1 ring 2 and ring 3) between baseline before and after treatment. There was statistically significant correlation between delta amplitude and delta implicit time and (macular thickness, HBA1C and BCVA) in (Ring 1, Ring 2 and Ring 3) among studied cases (P<0.05).
Conclusion: This study added evidence for the contribution of anti-VEGFs, particularly Ranibizumab, in improving macular function in cases with DME. Postsurgical improvement in VA was accompanied by diminished macular thickness and improved P1 amplitude in the central ring measured by mf-ERG.

Keywords

Main Subjects